Report of Foreign Issuer (6-k)
May 03 2016 - 4:52PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May, 2016
Commission File Number: 001-37423
Biotie Therapies Oyj
(Exact name of registrant as specified
in its charter)
Biotie Therapies Corp.
(Translation of registrant’s name
into English)
Joukahaisenkatu 6, FI-20520
Turku, Finland
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
INCORPORATION BY REFERENCE
This report on Form 6-K shall be deemed to be incorporated by
reference into the registration statement on Form S-8 (Registration Number 333-206484) of Biotie Therapies Corp. and to be a part
thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or
furnished.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
|
|
BIOTIE THERAPIES CORP.
|
|
|
|
|
|
|
|
|
By:
|
/s/ David Cook
|
|
|
|
|
|
Name:
|
David Cook
|
|
|
|
|
|
Title:
|
Chief Financial Officer
|
Date: May 03, 2016
EXHIBIT INDEX
|
Exhibit Number
|
Description
|
|
99.1
|
Stock Exchange Release dated May 03, 2016 (4:30 p.m. EET):
RESOLUTIONS OF THE ANNUAL GENERAL MEETING OF BIOTIE THERAPIES CORP. AND ORGANIZATION OF THE BOARD
|
BIOTIE THERAPIES CORP. (NASDAQ:BITI)
Historical Stock Chart
From Mar 2024 to Apr 2024
BIOTIE THERAPIES CORP. (NASDAQ:BITI)
Historical Stock Chart
From Apr 2023 to Apr 2024
